Droperidol
- TRADE NAMES: Dehydrobenzperidol; Droleptan; Droperidol; Inapsin; Inapsine (Akorn); Sintodian; Xomolix (ProStrakan)
- INDICATIONS: Tranquilizer and antiemetic in surgical procedures
- CLASS: Antiemetic, Antipsychotic, Butyrophenone
- HALF-LIFE: 2.3 hours
Amiodarone, Amisulpride, Amitriptyline, Arsenic, Atomoxetine, Azithromycin, Chloroquine, CNS depressants, Cyclobenzaprine, Disopyramide, Duloxetine, Eszopiclone, Fluoxetine, Fluvoxamine, Hydromorphone, Hydroxychloroquine, Levomepromazine, Lurasidone, Macrolides, Metaxalone, Milnacipran, Moxifloxacin, Paliperidone, Pentamidine, Pimozide, QT prolonging agents, Quinine, Ramelteon, Sertraline, Sotalol, Sulpiride, Tamoxifen, Tapentadol, Thiopental, Tiagabine, Tricyclic antidepressants
PREGNANCY CATEGORY: C
Contra-indicated in patients with known or suspected QT prolongation.
This product is not available in the European market.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
